Skip to main content
OpenTrials

Clinical trial condition

Coronavirus Infections

Explore clinical trials studying Coronavirus Infections. Study availability and eligibility vary by location and protocol.

701 public trials 29 recruiting studies
Refine in advanced search Browse all conditions

Coronavirus Infections trial results

Completed

Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

NCT06729606

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +11 more
Locations
  • Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue Tucson, Arizona, United States
  • UCSF Fresno (Site 203-005), 155 N. Fresno Street Fresno, California, United States
  • VA Loma Linda Healthcare System (Site 074-017), 11201 Benton Street Loma Linda, California, United States
  • Cedars-Sinai Medical Center (Site 208-002), 8700 Beverly Boulevard Los Angeles, California, United States
View all 40 locations
View Trial Details
Completed

Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

NCT06729593

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +11 more
Locations
  • Banner University Medical Center Tucson (Site 206-004), 1625 N. Campbell Avenue Tucson, Arizona, United States
  • UCSF Fresno (Site 203-005), 155 N. Fresno Street Fresno, California, United States
  • VA Loma Linda Healthcare System (Site 074-017), 11201 Benton Street Loma Linda, California, United States
  • Cedars-Sinai Medical Center (Site 208-002), 8700 Beverly Boulevard Los Angeles, California, United States
View all 40 locations
View Trial Details
Completed

Sarilumab COVID-19

NCT04327388

Conditions
Corona Virus Infection, Coronaviridae Infections, Coronavirus Infections, +4 more
Locations
  • Investigational Site Number 0320001 Caba, Argentina
  • Investigational Site Number 0320003 Caba, Argentina
  • Investigational Site Number 0320004 Caba, Argentina
  • Investigational Site Number 0760003 Porto Alegre, Brazil
View all 47 locations
View Trial Details
Completed

A Phase 1b Trial to Evaluate Safety and Effect of SAR443122 on Immune System in Severe COVID-19

NCT04469621

Conditions
Corona Virus Infection, Coronaviridae Infections, Coronavirus Infections, +4 more
Locations
  • Investigational Site Number 0320001 Caba, Argentina
  • Investigational Site Number 0760003 Porto Alegre, Brazil
  • Investigational Site Number 0760001 São José do Rio Preto, Brazil
  • Investigational Site Number 0760002 São Paulo, Brazil
View Trial Details

Related conditions